DEXAMETHASONE
Night Sweats
M.D. Anderson Cancer CenterSmall moleculePhase 2Dormant
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 47/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Night Sweats cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
cc-5013 M.D. Anderson Cancer Center | Phase 2 | B |
Ex Vivo-Activated Autologous Lymph Node Lymphocytes M.D. Anderson Cancer Center | Phase 2 | B |
Obinutuzumab M.D. Anderson Cancer Center | Phase 2 | B |
Humax-Cd20 M.D. Anderson Cancer Center | Phase 2 | B |
Cediranib City of Hope Medical Center | Phase 1 | CC |
RITONAVIR City of Hope Medical Center | Phase 1 | CC |
Metformin City of Hope Medical Center | Phase 1 | CC |
Same molecule, other indications
DEXAMETHASONE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →